FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q38605655> ?p ?o ?g. }

• Q38605655 description "2015 nî lūn-bûn" @default.
• Q38605655 description "2015年の論文" @default.
• Q38605655 description "2015年論文" @default.
• Q38605655 description "2015年論文" @default.
• Q38605655 description "2015年論文" @default.
• Q38605655 description "2015年論文" @default.
• Q38605655 description "2015年論文" @default.
• Q38605655 description "2015年论文" @default.
• Q38605655 description "2015年论文" @default.
• Q38605655 description "2015年论文" @default.
• Q38605655 description "2015年论文" @default.
• Q38605655 description "2015年论文" @default.
• Q38605655 description "2015年论文" @default.
• Q38605655 description "2015년 논문" @default.
• Q38605655 description "article científic" @default.
• Q38605655 description "article scientific" @default.
• Q38605655 description "article scientifique" @default.
• Q38605655 description "articol științific" @default.
• Q38605655 description "articolo scientifico" @default.
• Q38605655 description "artigo científico" @default.
• Q38605655 description "artigo científico" @default.
• Q38605655 description "artigo científico" @default.
• Q38605655 description "artikel ilmiah" @default.
• Q38605655 description "artikull shkencor" @default.
• Q38605655 description "artikulong pang-agham" @default.
• Q38605655 description "artykuł naukowy" @default.
• Q38605655 description "artículo científico" @default.
• Q38605655 description "artículu científicu espublizáu en 2015" @default.
• Q38605655 description "bilimsel makale" @default.
• Q38605655 description "bài báo khoa học" @default.
• Q38605655 description "naučni članak" @default.
• Q38605655 description "scienca artikolo" @default.
• Q38605655 description "scientific article published on 21 September 2015" @default.
• Q38605655 description "scientific article published on 21 September 2015" @default.
• Q38605655 description "scientific article published on 21 September 2015" @default.
• Q38605655 description "teaduslik artikkel" @default.
• Q38605655 description "tieteellinen artikkeli" @default.
• Q38605655 description "tudományos cikk" @default.
• Q38605655 description "vedecký článok" @default.
• Q38605655 description "vetenskaplig artikel" @default.
• Q38605655 description "videnskabelig artikel" @default.
• Q38605655 description "vitenskapelig artikkel" @default.
• Q38605655 description "vitskapeleg artikkel" @default.
• Q38605655 description "vědecký článek" @default.
• Q38605655 description "wetenschappelijk artikel" @default.
• Q38605655 description "wissenschaftlicher Artikel" @default.
• Q38605655 description "επιστημονικό άρθρο" @default.
• Q38605655 description "мақолаи илмӣ" @default.
• Q38605655 description "наукова стаття, опублікована у вересні 2015" @default.
• Q38605655 description "научна статия" @default.
• Q38605655 description "научная статья" @default.
• Q38605655 description "научни чланак" @default.
• Q38605655 description "научни чланак" @default.
• Q38605655 description "מאמר מדעי" @default.
• Q38605655 description "مقالة علمية نشرت في 21 سبتمبر 2015" @default.
• Q38605655 description "বৈজ্ঞানিক নিবন্ধ" @default.
• Q38605655 description "บทความทางวิทยาศาสตร์" @default.
• Q38605655 description "სამეცნიერო სტატია" @default.
• Q38605655 name "13,845 home therapy infusions with velaglucerase alfa exemplify safety of velaglucerase alfa and increased compliance to every-other-week intravenous enzyme replacement therapy for Gaucher disease" @default.
• Q38605655 name "13,845 home therapy infusions with velaglucerase alfa exemplify safety of velaglucerase alfa and increased compliance to every-other-week intravenous enzyme replacement therapy for Gaucher disease" @default.
• Q38605655 name "13,845 home therapy infusions with velaglucerase alfa exemplify safety of velaglucerase alfa and increased compliance to every-other-week intravenous enzyme replacement therapy for Gaucher disease" @default.
• Q38605655 type Item @default.
• Q38605655 label "13,845 home therapy infusions with velaglucerase alfa exemplify safety of velaglucerase alfa and increased compliance to every-other-week intravenous enzyme replacement therapy for Gaucher disease" @default.
• Q38605655 label "13,845 home therapy infusions with velaglucerase alfa exemplify safety of velaglucerase alfa and increased compliance to every-other-week intravenous enzyme replacement therapy for Gaucher disease" @default.
• Q38605655 label "13,845 home therapy infusions with velaglucerase alfa exemplify safety of velaglucerase alfa and increased compliance to every-other-week intravenous enzyme replacement therapy for Gaucher disease" @default.
• Q38605655 prefLabel "13,845 home therapy infusions with velaglucerase alfa exemplify safety of velaglucerase alfa and increased compliance to every-other-week intravenous enzyme replacement therapy for Gaucher disease" @default.
• Q38605655 prefLabel "13,845 home therapy infusions with velaglucerase alfa exemplify safety of velaglucerase alfa and increased compliance to every-other-week intravenous enzyme replacement therapy for Gaucher disease" @default.
• Q38605655 prefLabel "13,845 home therapy infusions with velaglucerase alfa exemplify safety of velaglucerase alfa and increased compliance to every-other-week intravenous enzyme replacement therapy for Gaucher disease" @default.
• Q38605655 P1433 Q38605655-13358F80-55E9-415D-B816-EF35EB332726 @default.
• Q38605655 P1476 Q38605655-6A707B14-A41A-4E38-B3E0-E9D7EFCE03F0 @default.
• Q38605655 P2093 Q38605655-0A671FD4-E16F-4833-9D32-A14EEADEAA3A @default.
• Q38605655 P2093 Q38605655-0D6EF304-03B9-4A9E-84AC-1A16B281DCE6 @default.
• Q38605655 P2093 Q38605655-59E6217F-3519-4159-90BD-94926DAF904A @default.
• Q38605655 P2093 Q38605655-910A1E7C-313D-4614-B16A-6EA8B7DA60A3 @default.
• Q38605655 P2093 Q38605655-948BD8F3-DFE3-4F6C-B43D-67F6E9D3CF8E @default.
• Q38605655 P2093 Q38605655-F6FA1F67-AC4A-4358-86E4-CC0C32FB3B22 @default.
• Q38605655 P304 Q38605655-9BF1434D-E005-4081-BBBF-A316255474B3 @default.
• Q38605655 P31 Q38605655-CC8514ED-9735-4FAC-B48B-86D020A6416D @default.
• Q38605655 P356 Q38605655-4E01EE13-4F10-429F-BDD2-933E00B34D87 @default.
• Q38605655 P407 Q38605655-97601BE7-4B3D-43B5-BA2D-6C67EC77EB15 @default.
• Q38605655 P433 Q38605655-9E4CD882-1B8C-4BA0-86C9-CA3C0D273007 @default.
• Q38605655 P478 Q38605655-3C0BBE4B-0CC7-40F8-8F4A-4FA6097DDD5B @default.
• Q38605655 P577 Q38605655-296B679A-AEDB-4F0A-8568-3C497C4D1B55 @default.
• Q38605655 P5875 Q38605655-30DE9EB1-E1D1-4305-B67E-CF5554329735 @default.
• Q38605655 P698 Q38605655-7BBDCD31-E3E9-47C6-8AC6-1322C4DB2093 @default.
• Q38605655 P921 Q38605655-0B16E30A-648F-4C5B-A408-229FDB560E3D @default.
• Q38605655 P921 Q38605655-693CD58F-F0E9-403B-AA57-A94F0614C812 @default.
• Q38605655 P356 J.BCMD.2015.09.002 @default.
• Q38605655 P698 26460268 @default.
• Q38605655 P1433 Q15758051 @default.
• Q38605655 P1476 "13,845 home therapy infusions with velaglucerase alfa exemplify safety of velaglucerase alfa and increased compliance to every-other-week intravenous enzyme replacement therapy for Gaucher disease" @default.
• Q38605655 P2093 "Anat Oz" @default.
• Q38605655 P2093 "Ari Zimran" @default.
• Q38605655 P2093 "Aya Abrahamov" @default.
• Q38605655 P2093 "Deborah Elstein" @default.
• Q38605655 P2093 "Hagit Baris" @default.
• Q38605655 P2093 "Naama Arbel" @default.
• Q38605655 P304 "415-418" @default.
• Q38605655 P31 Q13442814 @default.
• Q38605655 P356 "10.1016/J.BCMD.2015.09.002" @default.

• next